RPA is an important component of DNA replication, repair and recombination, but its involvement in the signaling of cell-cycle checkpoints is not well understood. In this study, we show that knockdown of RPA1 by siRNA duplexes induces ATM (Ser1981) and Chk2 (Thr68), but not Chk1 (Ser345) phosphorylation and results in p21 upregulation in HeLa cells. However, the induction of Chk2 (Thr68) phosphorylation and p21 expression by RPA1 siRNA transfection can be completely blocked by the ATM inhibitor caffeine. Moreover, transfection of siRNAs targeting ATM dramatically reduces Chk2 (Thr68) phosphorylation in RPA1 knockdown cells. Taken together, these results suggest that loss of RPA1 activates the Chk2 signaling pathway in an ATM-dependent manner.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.febslet.2004.11.066DOI Listing

Publication Analysis

Top Keywords

chk2 thr68
12
loss rpa1
8
rpa1 sirna
8
phosphorylation p21
8
thr68 phosphorylation
8
chk2
5
rpa1 induces
4
induces chk2
4
phosphorylation
4
chk2 phosphorylation
4

Similar Publications

Background: Colorectal cancer (CRC), the most common cancer type, causes high morbidity and mortality. Patients who develop drug resistance to oxaliplatin-based regimens have short overall survival. Thus, identifying molecules involved in the development of oxaliplatin resistance is critical for designing therapeutic strategies.

View Article and Find Full Text PDF

p53 as a unique target of action of cisplatin in acute leukaemia cells.

J Cell Mol Med

September 2022

Cellomics and Toxicogenomics Research Laboratory, NIH/NIMHD-RCMI Center for Health Disparities Research, Jackson State University, Jackson, Mississippi, USA.

Acute promyelocytic leukaemia (APL) occurs in approximately 10% of acute myeloid leukaemia patients. Arsenic trioxide (ATO) has been for APL chemotherapy, but recently several ATO-resistant cases have been reported worldwide. Cisplatin (CDDP) enhances the toxicity of ATO in ovarian, lung cancer, chronic myelogenous leukaemia, and HL-60 cells.

View Article and Find Full Text PDF

Chronic hepatitis caused by infection with the Hepatitis B virus is a life-threatening condition. In fact, 1 million people die annually due to liver cirrhosis or hepatocellular carcinoma. Recently, several studies demonstrated a molecular connection between the host DNA damage response (DDR) pathway and HBV replication and reactivation.

View Article and Find Full Text PDF
Article Synopsis
  • DNA damage is a common occurrence in cells caused by factors like radiation and certain drugs, and the DNA damage response (DDR) system works to repair this damage, prevent tumors, and maintain cell health.
  • This study evaluated specific DDR biomarkers (γH2AX, p-ATM, and p-CHK2) in patients with immunodeficiencies due to defects in DNA repair mechanisms, finding reduced responses in patients with ataxia telangiectasia and unusual delayed responses in those with non-homologous end-joining defects.
  • While these biomarkers can help diagnose certain types of DNA repair issues, they have limitations and may not reliably identify all deficiencies, such as ARTEMIS deficiency, highlighting the need for careful
View Article and Find Full Text PDF

Far-infrared irradiation inhibits breast cancer cell proliferation independently of DNA damage through increased nuclear Ca/calmodulin binding modulated-activation of checkpoint kinase 2.

J Photochem Photobiol B

June 2021

Department of Molecular Medicine, College of Medicine, Graduate Program in System Health Science and Engineering, Ewha Womans University, 25 Magokdong-ro-2-gil, Gangseo-gu, Seoul 07804, South Korea. Electronic address:

Far-infrared (FIR) irradiation is reported to inhibit cell proliferation in various types of cancer cells; the underlying mechanism, however, remains unclear. We explored the molecular mechanisms using MDA-MB-231 human breast cancer cells. FIR irradiation significantly inhibited cell proliferation and colony formation compared to hyperthermal stimulus, with no alteration in cell viability.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!